1.1 	A bill for an act
1.2 	relating to health; requiring a study of cervical cancer and the human papilloma 
1.3 	virus vaccine.
1.4 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.5 	Section 1. CERVICAL CANCER PREVENTION AND HUMAN PAPILLOMA 
1.6 	VIRUS VACCINE STUDY.
 1.7 	(a) The commissioner of health shall implement the following recommendations 
1.8 	from the cervical cancer prevention plan that was submitted to the legislature in January 
1.9 	2006:
1.10 	(1) conduct research to identify women who have not been screened;
1.11 	(2) conduct research among identified women to better understand reasons for 
1.12 	failure to be screened and to develop effective interventions;
1.13 	(3) design and implement targeted media campaigns;
1.14 	(4) implement intensive outreach in immigrant and refugee populations;
1.15 	(5) make translation services more widely available;
1.16 	(6) improve information provided to older patients and joint decision making 
1.17 	between providers and older patients; and
1.18 	(7) conduct a follow-back study of Minnesota women diagnosed with cervical 
1.19 	cancer.
1.20 	(b) The commissioner shall continue the study required under Laws 2005, First 
1.21 	Special Session chapter 4, article 6, section 52, if appropriate, and shall conduct a study, in 
1.22 	collaboration with the Minnesota Immunization Practices Advisory Committee, on the 
1.23 	human papilloma virus vaccine, including, but not limited to, the following: 
1.24 	(1) the risks and benefits of the human papilloma virus vaccine;
2.1 	(2) the availability and effectiveness of the vaccine;
2.2 	(3) the extent to which health plan companies cover the cost of this vaccination; and
2.3 	(4) ways to cover the cost of vaccination for persons without coverage.
2.4 	(c) The commissioner shall submit a report to the legislature by February 1, 2008, 
2.5 	reporting on the implementation described in paragraph (a), the findings of the studies 
2.6 	described in paragraph (b), and recommendations as to whether the human papilloma virus 
2.7 	vaccine should be made mandatory statewide.

2.8 	Sec. 2. HUMAN PAPILLOMA VIRUS MATERIALS.
 2.9 	(a) The commissioner of health shall develop education materials in consultation 
2.10 	with the Minnesota Immunization Practices Advisory Committee that contain information 
2.11 	regarding the risks associated with the human papilloma virus and cervical cancer and the 
2.12 	availability, effectiveness, and potential risks of the human papilloma virus vaccine.
2.13 	(b) Once the materials are available, the commissioner shall notify each school in 
2.14 	this state of the availability of the materials described in this section and shall make those 
2.15 	materials available on the department's Web site.